Aridis Pharmaceuticals - 52 Year Dividend History | ARDS
Historical dividend payout and yield for Aridis Pharmaceuticals (ARDS) since 1971. The current TTM dividend payout for Aridis Pharmaceuticals (ARDS) as of July 18, 2023 is $0.00. The current dividend yield for Aridis Pharmaceuticals as of July 18, 2023 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.003B |
$0.003B |
|
Aridis Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the discovery and development of immunotherapy using fully human monoclonal antibodies to treat life-threatening infections. The company's product pipeline consists of AR-301, AR-105, AR-101, AR-401, AR-201 and AR-501 which are in clinical stages. Aridis Pharmaceuticals, Inc. is based in San Jose, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
